Print this page    •   Back to Web version of article

Medical News
New Experimental Drug Blocks HIV Infection Early, Scientists Report

December 23, 2010

"Scientists are reporting early but promising results from a new drug that blocks HIV as it attempts to invade human cells," HealthDay News/U.S. News & World Report. "The approach differs from most current antiretroviral therapy, which tries to limit the virus only after it has gained entry to cells," the news service adds (Gardner, 12/22). "The drug, being developed by small privately held Hannover-based firm VIRO Pharmaceuticals, is called VIR-576 and reduced the amount of HIV infection in the blood by as much 95 percent in an early-stage trial of 18 patients," Reuters reports (Kelland, 12/23). "At the same time, adverse effects were few and mainly involved injection site reactions, [researchers] reported online in Science Translational Medicine," MedPage Today reports (Smith, 12/22).

Back to other news for December 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebodypro.com/content/art59954.html

General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.